Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126815682 | 12681568 | 2 | F | 2016 | 20160919 | 20160824 | 20160928 | EXP | DE-SA-2016SA154440 | AVENTIS | 40.00 | YR | A | M | Y | 0.00000 | 20160928 | PH | DE | DE |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126815682 | 12681568 | 1 | PS | APIDRA SOLOSTAR | INSULIN GLULISINE | 1 | Subcutaneous | Y | 6F422A | 21629 | SOLUTION FOR INJECTION | ||||||||
| 126815682 | 12681568 | 2 | C | SOLOSTAR | DEVICE | 1 | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 126815682 | 12681568 | 1 | Diabetes mellitus |
| 126815682 | 12681568 | 2 | Diabetes mellitus |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 126815682 | 12681568 | DS |
| 126815682 | 12681568 | LT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 126815682 | 12681568 | Blood glucose increased |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 126815682 | 12681568 | 1 | 201606 | 201608 | 0 | |
| 126815682 | 12681568 | 2 | 201606 | 201608 | 0 |